With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback